Skip to content
Back to EVGN

Evogene Ltd.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
3
Purchases
3
Sales
0
Purchase value
$692.78K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Leon RecanatiDirector
4
Filed Aug 13, 2026Period of report Aug 11, 20260001178913-26-004095
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 11, 2026
Ordinary Shares460,000$0.635$292.10K1,343,886Direct
Filing footnotes · 2
  1. F1There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  2. F2The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested by the one-year anniversary of the August 18, 2025 grant date.
Open on SEC EDGAR
Leon RecanatiDirector
4
Filed Aug 5, 2026Period of report Aug 4, 20260001178913-26-003859
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseAug 4, 2026
Ordinary SharesF1800,000$0.50$400.00K883,886Direct
Filing footnotes · 3
  1. F1The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
  2. F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested on the one-year anniversary of the August 18, 2025 grant date.
Open on SEC EDGAR
Gabi TarcicChief Development Officer
4
Filed Aug 26, 2026Period of report Jun 4, 20260001178913-26-004259
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 4, 2026
Ordinary Shares1,129$0.60$677.401,129Direct
Filing footnotes · 2
  1. F1The options reported in this row vest over a period of four years, with 25% vesting upon the first anniversary of the November 20, 2024 grant date, and the remainder vesting on an equal quarterly basis (6.25% per quarter) over the following twelve quarters, such that all options will be fully vested on the four-year anniversary of the November 20, 2024 grant date.
  2. F2There were no transactions in the securities reported in this row, and the Reporting Person's holdings in these securities is being provided for informational purposes only.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.